Acquisition History / Kingsman Wealth Fund PCC - Aurisse Special Opportunities Fund / Mudhra Lifesciences Private Limited

Kingsman Wealth Fund PCC - Aurisse Special Opportunities Fund Acquires Mudhra Lifesciences Private Limited

Announced January 2024 — Price not disclosed (CCI combination order)

Kingsman Wealth Fund PCC - Aurisse Special Opportunities FundPharmaceuticals2024

What happened

Pharmaceutical manufacturer Acquired through Kingsman Wealth Fund PCC - Aurisse Special Opportunities Fund. Fund vehicle named; no separate manager named in the summary Source: https://www.cci.gov.in/images/summaryorders/en/summary1712287965.pdf

Acquirer
Kingsman Wealth Fund PCC - Aurisse Special Opportunities Fund
Target
Mudhra Lifesciences Private Limited
Announced
January 2024
Price
Price not disclosed (CCI combination order)
Industry
Pharmaceuticals
Buyer type
Private equity
Fund vehicle
Kingsman Wealth Fund PCC - Aurisse Special Opportunities Fund
Status
Closed

By the numbers

Kingsman Wealth Fund PCC - Aurisse Special Opportunities Fund's acquisition history
1st of 1 tracked deals
Disclosed prices
0 of 1 Kingsman Wealth Fund PCC - Aurisse Special Opportunities Fund deals
Tracked acquisitions in 2024
157 across all acquirers
Kingsman Wealth Fund PCC - Aurisse Special Opportunities Fund in Pharmaceuticals
1 acquisition

Frequently Asked Questions About This Acquisition

When did Kingsman Wealth Fund PCC - Aurisse Special Opportunities Fund acquire Mudhra Lifesciences Private Limited?

Kingsman Wealth Fund PCC - Aurisse Special Opportunities Fund acquired Mudhra Lifesciences Private Limited on January 2024. This was Kingsman Wealth Fund PCC - Aurisse Special Opportunities Fund's 1st publicly tracked acquisition out of 1 we have on record.

How much did Kingsman Wealth Fund PCC - Aurisse Special Opportunities Fund pay for Mudhra Lifesciences Private Limited?

Kingsman Wealth Fund PCC - Aurisse Special Opportunities Fund paid Price not disclosed (CCI combination order) for Mudhra Lifesciences Private Limited.

What does Mudhra Lifesciences Private Limited do?

Pharmaceutical manufacturer Acquired through Kingsman Wealth Fund PCC - Aurisse Special Opportunities Fund. Fund vehicle named; no separate manager named in the summary Source: https://www.cci.gov.in/images/summaryorders/en/summary1712287965.pdf

What other Pharmaceuticals companies has Kingsman Wealth Fund PCC - Aurisse Special Opportunities Fund acquired?

Mudhra Lifesciences Private Limited is Kingsman Wealth Fund PCC - Aurisse Special Opportunities Fund's only publicly tracked acquisition in Pharmaceuticals so far.

Read the full article →

More Pharmaceuticals acquisitions